In an interview with Adam Colborn, JD, director of government relations for the Academy of Managed Care Pharmacy focuses on ...
A review article summarized the totality of evidence supporting the approval of the adalimumab biosimilar GP2017 (Hyrimoz; Sandoz) in the United States and Europe. A review article summarized the ...
On this episode of Not So Different, The Center for Biosimilars® discusses all the conference coverage, adalimumab data, and ...
Formycon, a Germany-based biosimilar manufacturer, shared that its revenues for 2023 were 83% higher than in 2022, reaching a ...
Two posters from the Academy of Managed Care Pharmacy (AMCP) annual meeting explore how an interchangeable insulin glargine ...
Two posters from the Academy of Managed Care Pharmacy (AMCP) annual meeting explore how an interchangeable insulin glargine biosimilar plays into Medicaid budgets and the top factors driving access to ...
Thanks to high biosimilar adoption rates within the community oncology setting, American Oncology Network saved upwards of ...
Despite current challenges in biosimilar market growth due to stakeholder disagreements, a recent commentary proposes that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results